These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17401142)

  • 21. Transfer of C-terminal residues of human apolipoprotein A-I to insect apolipophorin III creates a two-domain chimeric protein with enhanced lipid binding activity.
    Horn JVC; Ellena RA; Tran JJ; Beck WHJ; Narayanaswami V; Weers PMM
    Biochim Biophys Acta Biomembr; 2017 Aug; 1859(8):1317-1325. PubMed ID: 28434970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion of single amino acid E235 affects the structure and lipid interaction of human apolipoprotein A-I C-terminal peptides.
    Tanaka T; Tanaka M; Sugiura M; Kawakami T; Aimoto S; Saito H
    Chem Pharm Bull (Tokyo); 2009 May; 57(5):499-503. PubMed ID: 19420782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid-binding studies of human apolipoprotein A-I and its terminally truncated mutants.
    Fang Y; Gursky O; Atkinson D
    Biochemistry; 2003 Nov; 42(45):13260-8. PubMed ID: 14609337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folding and stability of the C-terminal half of apolipoprotein A-I examined with a Cys-specific fluorescence probe.
    Behling Agree AK; Tricerri MA; Arnvig McGuire K; Tian SM; Jonas A
    Biochim Biophys Acta; 2002 Feb; 1594(2):286-96. PubMed ID: 11904224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model.
    Saito H; Dhanasekaran P; Nguyen D; Holvoet P; Lund-Katz S; Phillips MC
    J Biol Chem; 2003 Jun; 278(26):23227-32. PubMed ID: 12709430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between the N- and C-terminal domains modulates the stability and lipid binding of apolipoprotein A-I.
    Koyama M; Tanaka M; Dhanasekaran P; Lund-Katz S; Phillips MC; Saito H
    Biochemistry; 2009 Mar; 48(11):2529-37. PubMed ID: 19239199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction.
    Huang W; Sasaki J; Matsunaga A; Han H; Li W; Koga T; Kugi M; Ando S; Arakawa K
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):210-6. PubMed ID: 10634820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ins (cell) and outs (plasma) of apolipoprotein A-V.
    Forte TM; Shu X; Ryan RO
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S150-5. PubMed ID: 19050314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of apolipoprotein A-IV enhances lipid secretion in IPEC-1 cells by increasing chylomicron size.
    Lu S; Yao Y; Cheng X; Mitchell S; Leng S; Meng S; Gallagher JW; Shelness GS; Morris GS; Mahan J; Frase S; Mansbach CM; Weinberg RB; Black DD
    J Biol Chem; 2006 Feb; 281(6):3473-83. PubMed ID: 16338933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interfacial exclusion pressure determines the ability of apolipoprotein A-IV truncation mutants to activate cholesterol ester transfer protein.
    Weinberg RB; Anderson RA; Cook VR; Emmanuel F; Denèfle P; Tall AR; Steinmetz A
    J Biol Chem; 2002 Jun; 277(24):21549-53. PubMed ID: 11940599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing the lipid-free structure and stability of apolipoprotein A-I by mutation.
    Gorshkova IN; Liadaki K; Gursky O; Atkinson D; Zannis VI
    Biochemistry; 2000 Dec; 39(51):15910-9. PubMed ID: 11123918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein A-V is a potent modulator of HDL and VLDL components in preadolescent children.
    Abe Y; Okada T; Kuromori Y; Hara M; Saito E; Iwata F; Harada K; Mugishima H
    J Atheroscler Thromb; 2009 Apr; 16(2):121-6. PubMed ID: 19403991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular lipid droplet targeting by apolipoprotein A-V requires the carboxyl-terminal segment.
    Shu X; Ryan RO; Forte TM
    J Lipid Res; 2008 Aug; 49(8):1670-6. PubMed ID: 18450648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families.
    Nilsson SK; Christensen S; Raarup MK; Ryan RO; Nielsen MS; Olivecrona G
    J Biol Chem; 2008 Sep; 283(38):25920-7. PubMed ID: 18603531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlement.
    Sharma V; Ryan RO; Forte TM
    Biochim Biophys Acta; 2012 May; 1821(5):795-9. PubMed ID: 22209939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-guided protein engineering modulates helix bundle exchangeable apolipoprotein properties.
    Kiss RS; Weers PM; Narayanaswami V; Cohen J; Kay CM; Ryan RO
    J Biol Chem; 2003 Jun; 278(24):21952-9. PubMed ID: 12684504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo.
    Chroni A; Liu T; Gorshkova I; Kan HY; Uehara Y; Von Eckardstein A; Zannis VI
    J Biol Chem; 2003 Feb; 278(9):6719-30. PubMed ID: 12488454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expressed protein ligation-mediated template protein extension.
    Kamei A; Hauser PS; Beckstead JA; Weers PM; Ryan RO
    Protein Expr Purif; 2012 Jun; 83(2):113-6. PubMed ID: 22487214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational flexibility of the N-terminal domain of apolipoprotein a-I bound to spherical lipid particles.
    Kono M; Okumura Y; Tanaka M; Nguyen D; Dhanasekaran P; Lund-Katz S; Phillips MC; Saito H
    Biochemistry; 2008 Oct; 47(43):11340-7. PubMed ID: 18831538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinctive structure and function of human apolipoprotein variant ApoA-IV-2.
    Weinberg RB; Jordan MK; Steinmetz A
    J Biol Chem; 1990 Oct; 265(30):18372-8. PubMed ID: 2211707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.